Over 130 genes and 150 traits analysed to provide personalised skin careGeneIQ – India's first medico-aesthetic clinic application reinforces our…
INNSBRUCK, Austria, Sept. 22, 2025 /PRNewswire/ -- AV-Comparatives, the leading independent cybersecurity testing lab, today announced the results of its…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
19 September 2025 - The International Olympic Committee (IOC) Executive Board (EB) today took the decision to reallocate Olympic medals, diplomas and medallist…
IRVINE, Calif.--(BUSINESS WIRE)--Five Point Holdings, LLC (“Five Point”) (NYSE: FPH) announced today that the cash tender offer (the “Offer”) commenced…
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:…
Published in the Journal of Clinical Oncology, results showed no difference in any outcomes, including overall survival, at two years…
New ECW Results Report highlights transformative education outcomes for children and adolescents in emergencies and protracted crises and calls for…
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants…
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…